Edluar approved for insomnia

EDULAR (zolpidem tartrate) 5mg, 10mg sublingual tablets by Meda Pharmaceuticals
EDULAR (zolpidem tartrate) 5mg, 10mg sublingual tablets by Meda Pharmaceuticals
The FDA has approved Orexo's Edluar (zolpidem, [formerly known as Sublinox]), an imidazopyridine hypnotic, for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Edluar will be available as a sublingual tablet in 5mg and 10mg strengths.

Edluar is expected to be available by Orexo's partner Meda during the 2nd half of 2009.  

For more information call (732) 564-2200 or visit www.medpointepharma.com.